Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decline in Short Interest

Posted by Donna Armstrong on Sep 11th, 2026

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) saw a significant drop in short interest in the month of August. As of August 31st, there was short interest totaling 18,768 shares, a drop of 78.8% from the August 15th total of 88,674 shares. Based on an average daily volume of 183,620 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.8% of the company’s stock are sold short.

Arcadia Biosciences Price Performance

Shares of RKDA stock opened at $0.45 on Friday. The company’s fifty day moving average price is $0.59 and its two-hundred day moving average price is $1.02. The firm has a market capitalization of $1.08 million, a P/E ratio of -0.10 and a beta of 0.53. Arcadia Biosciences has a 12 month low of $0.38 and a 12 month high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last released its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing the consensus estimate of ($0.56) by ($1.53). The business had revenue of $1.44 million during the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Check Out Our Latest Stock Report on Arcadia Biosciences

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.